Spatial omics is an emerging analytical paradigm that addresses the loss of spatial context inherent in conventional single-cell omics by integrating molecular information with spatial coordinates in intact tissues. This review outlines the conceptual framework and technological evolution of spatial omics and systematically compares major platforms based on next-generation sequencing (NGS) and imaging technologies. Key differences in resolution, analytical scope, and data characteristics are discussed for representative NGS-based approaches, including Visium, high-definition Visium spatial transcriptomic technology (Visium HD), and Stereo-seq, and imaging-based methods, including Xenium, MERSCOPE, and CosMx Spatial Molecular Imager. Recent advances in spatial multi-omics are also highlighted, with emphasis on the integration of transcriptomic, proteomic, and epigenomic data within the same spatial framework. We further describe essential computational strategies, including cell segmentation, spatial domain identification, and inference of cell-cell interactions, and demonstrate how spatial omics data can be translated into biological insights. Applications in oncology and neuroscience are reviewed, illustrating how spatial omics enables characterization of tumor microenvironment heterogeneity, prediction of immunotherapy responses, and investigation of neurodegenerative disease progression. Finally, current challenges, including data complexity, lack of standardization, and high cost, are discussed, along with future perspectives such as integration with artificial intelligence, three-dimensional tissue reconstruction, and real-time in vivo analysis. This review provides a comprehensive foundation for applying spatial omics in precision medicine and next-generation pathology.
The thoracolumbar junction is a critical transitional region where the relatively immobile, rib-stabilized thoracic spine meets the more mobile lumbar spine, creating a site of markedly increased mechanical loading. This biomechanical vulnerability contributes to the frequent occurrence of diverse spinal pathologies at this level, including degenerative disease, traumatic injury, infection, and neoplasm. Magnetic resonance imaging (MRI) remains the reference standard and provides detailed multiplanar assessment of canal compromise, spinal cord and cauda equina compression, posterior ligamentous complex disruption, abnormal marrow signal, epidural or paravertebral extension, and associated soft tissue changes across these disease entities. Because missed pathology in this region can have serious neurological consequences, routine lumbar spine MRI protocols should extend superiorly to at least the T10 vertebral level to reduce diagnostic misses and support timely, appropriate management.
Competency-based medical education emphasizes formative assessment and longitudinal portfolio review; however, the resulting workload is increasingly difficult for faculty members to sustain. Generative artificial intelligence (GenAI) and large language models (LLMs), such as ChatGPT, Gemini, and Claude, offer opportunities to alleviate these burdens while enriching teaching and learning. This narrative review synthesizes peer-reviewed literature published between January 2023 and April 2026, retrieved from PubMed/MEDLINE, Scopus, Web of Science, Google Scholar, and Education Resources Information Center (ERIC), on the practical applications of GenAI and LLMs in medical education. Five core domains were identified: simulation of clinical reasoning, formative assessment and e-portfolio evaluation, support for self-directed learning, curriculum design, and communication skills training. Important challenges and ethical considerations are also discussed, including cognitive offloading and the potential erosion of critical thinking, hallucinations and threats to academic integrity, data privacy and institutional compliance concerns, and the risk of widening the digital divide. Future directions include multimodal LLMs and integrated clinical simulations, longitudinal competency tracking, faculty development and institutionalization of artificial intelligence (AI) literacy, standardized evaluation frameworks and regulatory guidance, and ambient AI in smart educational environments. When integrated thoughtfully, GenAI and LLMs may reduce faculty workload and enrich the learner experience while preserving educators’ authority over competency judgments and the humanistic core of medical education. Realizing this potential will require coordinated investment in faculty’s AI literacy, robust governance, equity-focused deployment, and rigorous validation of AI-enhanced educational tools.
Telecytology is a clinically applicable component of telepathology that enables remote cytologic assessment through digital image transmission. In head and neck practice, its primary value lies in fine-needle aspiration (FNA) workflows for thyroid nodules, cervical lymph nodes, metastatic neck masses, and salivary gland lesions, in which rapid assessment of specimen adequacy and triage for ancillary studies can affect diagnostic yield and specimen use. This review summarizes the major telecytology platforms, including static-image transmission, dynamic real-time systems, robotic microscopy, and whole-slide imaging, and discusses their use in common head and neck cytopathology settings. The evidence base is strongest for thyroid FNA, which is supported by telecytology-specific studies and the broader literature on rapid on-site evaluation (ROSE). For cervical lymph nodes, metastatic neck masses, and salivary gland lesions, telecytology primarily serves as a procedural support tool for adequacy assessment, repeat-pass decision-making, and specimen triage, rather than as a universal substitute for conventional cytopathology review. Its limitations include operator dependence, field-selection bias, image quality, the need to assess cytology specimens across multiple focal planes, workflow integration, validation, and quality assurance. Implementation is also influenced by reimbursement, medicolegal responsibility, data security, and institutional resources. Current evidence supports the selective use of telecytology, with priority given to thyroid FNA and other ROSE-linked procedures in which adequacy assessment, repeat-pass decisions, or ancillary-test triage can affect specimen management, particularly when continuous on-site cytopathology coverage is limited. Wider adoption will require standardized workflows, site-specific validation, sustainable implementation models, and careful integration of whole-slide imaging and computational tools into clinically defined use cases.
Background Erythropoiesis-stimulating agent hyporesponsiveness (HypoESA) poses a significant challenge in the management of anemia among dialysis patients. However, the absence of consensus regarding its definition and management has created an important gap between clinical guidelines and real-world practice. This study aimed to explore nephrologists’ perceptions and current practices related to the diagnosis and management of HypoESA.
Methods A 26-item cross-sectional survey was administered online to nephrologists affiliated with the Busan-Ulsan-Gyeongnam chapter of the Korean Society of Nephrology. The survey assessed respondent demographics, clinical experience, perceptions of HypoESA, diagnostic approaches, management strategies, and perceived predictive factors. Survey data were analyzed using descriptive statistics.
Results A total of 81 nephrologists responded to the survey (response rate, 38%). Substantial disagreement was observed regarding the definition of HypoESA, particularly with respect to criteria involving increases in ESA dosage. Chronic inflammation was most frequently identified as the primary underlying cause, with C-reactive protein considered the key diagnostic indicator. Increasing iron supplementation was reported as the most commonly preferred management strategy.
Conclusions Despite broad recognition of chronic inflammation as a central factor in HypoESA, nephrologists demonstrated considerable variability in their definitions and management approaches, creating barriers to standardized care. These findings underscore the urgent need for a unified definition of HypoESA to better align clinical guidelines with everyday practice and ultimately improve patient outcomes.
Background Accurate preoperative staging is crucial for determining treatment strategies in gastric cancer. However, discrepancies between clinical and pathological staging remain common. This study aimed to evaluate the frequency of preoperative staging discordance and to identify associated risk factors.
Methods We retrospectively analyzed 2,810 patients who underwent curative gastrectomy at a tertiary center between 2012 and 2021. Staging was determined according to the American Joint Committee on Cancer 8th edition criteria. Patients were categorized into concordant, overestimated, or underestimated groups based on discrepancies between clinical and pathological staging. Multivariate logistic regression analysis was performed to identify independent predictors of staging discordance.
Results The concordance rate between clinical and pathological staging was 81.3%. Overestimation occurred in 8.1% of cases (n=228), whereas underestimation was observed in 10.6% (n=298). Factors independently associated with overstaging included higher hemoglobin levels (odds ratio [OR], 1.14), lower tumor marker levels (carcinoembryonic antigen: OR, 0.97; carbohydrate antigen 19-9: OR, 0.99), and tumors located in the lower third of the stomach (OR, 1.79). Understaging was independently associated with decreased hemoglobin levels (OR, 0.84 per 1 g/dL increase) and involvement of the entire stomach (OR, 8.48).
Conclusions Staging discordance occurred in approximately 18.7% of patients with gastric cancer. Identification of these key predictors may facilitate more accurate preoperative assessment and support optimization of individualized surgical and therapeutic planning.
Citations
Citations to this article as recorded by
Beyond accuracy: interpreting preoperative staging discordance in gastric cancer Young Suk Park Kosin Medical Journal.2026; 41(2): 91. CrossRef
Background Patients with interstitial lung disease (ILD) often require high-dose glucocorticoid therapy, which increases the risk of osteoporosis. However, Korean data on bone mineral density (BMD) in patients with ILD remain limited. We aimed to evaluate changes in BMD before and after glucocorticoid therapy.
Methods Eligible participants were patients with ILD who were treated with prednisolone at a dose of ≥5 mg/day for at least 3 months during the study period (August 2020 to August 2021). BMD was measured at baseline and at 12 months. Body composition and bone metabolism markers were measured at baseline, 6 months, and 12 months.
Results Eighteen patients with non-idiopathic pulmonary fibrosis ILD were analyzed. BMD at the lumbar spine, femoral neck, and total hip decreased by 4.3%, 2.0%, and 1.8%, respectively (all p<0.05). Body weight and muscle mass did not change significantly, whereas body fat percentage increased from 31.6% to 34.9% (p<0.001). Vitamin D deficiency was present in 61% of the cohort (67% of males and 58% of females).
Conclusions At 12 months, glucocorticoid therapy was associated with rapid, lumbar-predominant bone loss. An increase in body fat despite preserved body weight may not be detected without body composition assessment. Vitamin D deficiency remained a concern, particularly in males.
Cutaneous metastases from colorectal cancer are rare, occurring in only 0.7%–5% of cases. They typically develop in the late stages of the disease and indicate widespread dissemination and poor prognosis. In rare instances, however, cutaneous metastasis may represent the first clinical manifestation of an underlying malignancy. Such presentations pose diagnostic challenges because they can closely mimic benign dermatologic conditions. We report the case of an 82-year-old female patient with a history of hypertension, degenerative joint disease, and depression who presented to a local orthopedic clinic with a painless skin mass on the right chest wall. Biopsy revealed adenocarcinoma, initially suspected to represent metastatic lung cancer. Further evaluation at our hospital, including abdominal computed tomography and colonoscopy, revealed a friable mass in the sigmoid colon with associated peritoneal and pulmonary metastases. Histopathologic examination confirmed well-differentiated adenocarcinoma. Immunohistochemistry demonstrated strong carcinoembryonic antigen and epithelial membrane antigen positivity, with a markedly elevated proliferative index. During hospitalization, a second cutaneous metastasis developed on the forehead—an exceptionally rare site for colorectal carcinoma spread. Given her poor overall condition, the patient and her family opted for palliative management, and she died 1 month after diagnosis. This case underscores the importance of recognizing cutaneous metastasis as a potential initial presentation of colorectal cancer. Early biopsy of unexplained skin lesions in older patients is crucial for timely diagnosis, appropriate management, and avoidance of diagnostic delay.
Hye Jin Kim, Hyo Eon Kwon, Seong Bin Ahn, Jin Ok Park, Eun Hye Cho, Do Hwa Im, Da Hyun Kim, Eun Jung Jung, Jung Mi Byun, Young Nam Kim, Kyung Bok Lee, Eun Kyoung You, Dae Hoon Jeong
Kosin Med J. 2026;41(2):169-174. Published online June 11, 2026
We report an extremely rare case of endometrial cancer diagnosed in a patient with Myhre syndrome. Myhre syndrome is a rare autosomal-dominant disorder caused by one of two heterozygous gain-of-function pathogenic variants in the SMAD4 gene. The condition is characterized by intellectual disability, hearing impairment, and distinctive facial features, including blepharophimosis, short palpebral fissures, maxillary hypoplasia, and a prominent nose. Additional clinical features include short stature, limited joint motion, skeletal abnormalities, and cardiovascular defects. Approximately 80 individuals with this genetic mutation have been reported worldwide, and only three cases of endometrial cancer have been documented to date. In Korea, a single case of Myhre syndrome has been reported in a 13-year-old female patient with developmental concerns. Here, we describe an exceptionally rare case of a 34-year-old female patient diagnosed with endometrial cancer associated with a SMAD4 gene mutation. To our knowledge, this is the first reported case in Korea of endometrial cancer occurring in a patient with Myhre syndrome. Although further functional studies are required, the recurrence of the same SMAD4 pathogenic variant in patients with Myhre syndrome who developed neoplasia suggests that this gain-of-function mutation may act as a predisposing factor for endometrial cancer.
Eosinophilia in patients undergoing hemodialysis (HD) is rare but can cause severe complications including intradialytic hypotension. Hypereosinophilia-associated acute intradialytic hypotension (HAIDH) typically develops within minutes of HD initiation and does not respond to changes in the dialyzer or dialysate. In this report, we describe a case of HAIDH associated with idiopathic hypereosinophilic syndrome that was successfully managed with corticosteroids, and we review previously reported cases.